FEATURED NEWS

• HDA Statement on FDA Commissioner Nominee Dr. Robert Califf

  November 12, 2021

  Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding President Biden’s nomination of Dr. Robert Califf as FDA Commissioner.

• HDA Foundation Survey Reveals Uneven Progress on Rx Product Serialization, with 2023 DSCSA Requirements Around the Corner

  November 1, 2021

  The pharmaceutical supply chain’s progress on implementing product serialization requirements to comply with the Drug Supply Chain Security Act (DSCSA) has slowed as the November 2023 deadline for compliance comes into view.

• White Paper Shows PSAOs Provide Meaningful Support to the Vast Majority of Independent Pharmacies

  October 28, 2021

  Approximately 80 percent of independent retail and small chain pharmacies choose to use Pharmacy Services Administrative Organizations (PSAOs), as evidenced in a new white paper produced by Avalere Health.

• Mauch and Gielen Reelected to Lead HDA Board of Directors

  September 27, 2021

  The Healthcare Distribution Alliance (HDA) today announced that Robert Mauch, PharmD, PhD, Group President of AmerisourceBergen, was elected to a second term as Chairman of the HDA Board of Directors. Chad Gielen, President/CEO of Louisiana Wholesale Drug Co., Inc. will again serve as Vice Chairman.

• Few Rx Supply Chain Stakeholders Prepared To Share DSCSA-Required Transaction Data

  September 15, 2021

  Results from a new HDA Research Foundation survey indicate that the pharmaceutical supply chain is entering a critical phase in achieving the transaction data connections required to comply with the Drug Supply Chain Security Act (DSCSA) in 2023.